The Bern Perioperative Biobank

NCT04767685 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 547

Last updated 2022-11-15

No results posted yet for this study

Summary

The goal of the research is to define clinically relevant molecular markers for increased risk of peri-/ postoperative organo-dysfunctions, inflammation, adverse events and disease progression. To better understand the perioperative impact the investigators aim to determine perioperative levels of molecular markers over time in the available samples and clinical data of the Bern perioperative Biobank (BPBB) cohort to finally increase quality of perioperative care of patients by permitting preventive measures to be taken early in patients at risk.

Conditions

  • Anesthesia
  • Surgical Procedure, Operative

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Frank Stüber, Prof. MD · Department of Anaesthesiology and Pain Medicine, Inselspital, University of Bern

  • Markus M Lüdi, MD · Department of Anaesthesiology and Pain Medicine, Inselspital, University of Bern

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04767685 on ClinicalTrials.gov